FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I)
, where A denotes -CH2-, -O- or -NR'-, in which R' denotes hydrogen or C1-6alkyl, or R' and R4 form C2-5alkylene; R1 denotes hydrogen, amine group, C1-6alkyl, hydroxy group, -NR'R", (C0-6alkylene)-NR'R", where R' and R" are independently selected from a group comprising hydrogen, C1-6alkyl, heteroalkyl, formyl, C1-6alkylcarbonyl, arylcarbonyl optionally substituted with halogenalkyl, C1-6alkylsulphonyl, arylsulphonyl or -(C0-6alkylene)-OR', where R' denotes hydrogen, C1-6alkyl, formyl or C1-6alkylcarbonyl; R2 , R2 and R2 independently denote hydrogen, halogen, C1-6alkyl or C1-6alkoxy group; R3 denotes hydrogen, C1-6alkyl, aryl-C1-6alkyl, aryl optionally substituted with halogen, or heteroaryl, where the heteroaryl is a monocyclic or bicyclic ring containing 5-6 ring atoms and at least one aromatic ring containing one or three ring heteroatoms selected fron N, O and S, where the remaining ring atoms are carbon atoms, and the bonding site of the heteroaryl radical must be on the aromatic ring; R4 denotes hydrogen, C1-6alkyl, aryl, C3-7cycloalkyl-C1-6alkyl, aryl-C1-6alkyl; R5 denotes hydrogen or C1-6alkyl; or R4 and R5 together with the carbon atom to which they are bonded, form an optionally substituted C3-7cycloalkyl ring; R6 denotes hydrogen or C1-6alkyl; and pharmaceutically acceptable salts thereof, where the term "aryl" denotes phenyl or naphthyl. The invention also relates to a pharmaceutical composition based on compounds of formula I and having a inhibitory activity towards chymase.
EFFECT: novel compounds which can inhibit chymase are obtained and can be used as medicinal agents.
22 cl, 79 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
VINYLOGOUS ACID DERIVATIVES AS CHYMASE INHIBITORS | 2007 |
|
RU2451013C2 |
SPIROOXYINDOLE DERIVATIVES AND APPLICATION THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2415143C2 |
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
DERIVATIVES OF 2-IMINOPYRROLIDINE | 2002 |
|
RU2270192C2 |
OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 1998 |
|
RU2215740C2 |
2-AMINOPYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THERAPY | 2001 |
|
RU2250898C2 |
SUBSTITUTED PYRAZOLOPYRIMIDINES, METHOD FOR PREPARING AND USING THEM AS DRUG | 2007 |
|
RU2450004C2 |
COMPOUNDS AND THEIR USING FOR DECREASING HORMONE-SENSITIVE LIPASE ACTIVITY | 2002 |
|
RU2317981C2 |
PHARMACEUTICAL COMPOUNDS | 2019 |
|
RU2821941C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2009 |
|
RU2503676C2 |
Authors
Dates
2011-08-10—Published
2006-11-22—Filed